Skip to main content
SpringerLink
Log in

Abemaciclib/palbociclib

Cutaneous reaction and lack of efficacy: 10 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Amigo M, et al. Presentation and management of diverse cutaneous reactions after cyclin-dependent kinase 4/6 inhibitor use. Journal of the American Academy of Dermatology 86: 1346-1348, No. 6, Jun 2022. Available from: URL: http://doi.org/10.1016/j.jaad.2021.04.092

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abemaciclib/palbociclib. Reactions Weekly 1939, 16 (2023). https://doi.org/10.1007/s40278-023-31424-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-31424-0

Search

Navigation